Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has assisted in connection with Samhällsbyggnadsbolaget’s listing on Nasdaq Stockholm
Mandate

Vinge has assisted in connection with Samhällsbyggnadsbolaget’s listing on Nasdaq Stockholm

September 26, 2019 Capital Markets and Public M&A

Vinge has assisted with counselling on securities law and transaction execution in connection with Samhällsbyggnadsbolaget i Norden AB (publ)’s list change of their B‑ and D‑shares from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market.

The prospectus was published on 18 September 2019 and the trading on Nasdaq Stockholm commenced 20 September 2019.

The company’s strategy is to own, manage and develop community service properties throughout the Nordic region and rental apartments in growth regions in Sweden. As of 30 June 2019, the
property portfolio consisted of 790 properties with a reported amount for investment properties totalling SEK 30.3 billion.

Vinge’s team has primarily consisted of Jesper Schönbeck, Malte Hedlund, Boris Kotur, Anders Sundin Lundberg and Nils Fredrik Dehlin. Maria Schultzberg, Victor Ericsson and Henrik Wastenson advised on tax issues.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025